- Home
- FGNX vs NRXS Comparison
FGNX vs NRXS Comparison
Compare FGNX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGNX
- NRXS
- Stock Information
- Founded
- FGNX 1932
- NRXS 2011
- Country
- FGNX United States
- NRXS United States
- Employees
- FGNX N/A
- NRXS N/A
- Industry
- FGNX Property-Casualty Insurers
- NRXS
- Sector
- FGNX Finance
- NRXS
- Exchange
- FGNX Nasdaq
- NRXS Nasdaq
- Market Cap
- FGNX 25.2M
- NRXS 25.8M
- IPO Year
- FGNX N/A
- NRXS 2023
- Fundamental
- Price
- FGNX $3.84
- NRXS $3.59
- Analyst Decision
- FGNX Strong Buy
- NRXS Strong Buy
- Analyst Count
- FGNX 1
- NRXS 1
- Target Price
- FGNX $8.00
- NRXS $7.00
- AVG Volume (30 Days)
- FGNX 1.0M
- NRXS 1.0M
- Earning Date
- FGNX 11-19-2025
- NRXS 11-11-2025
- Dividend Yield
- FGNX N/A
- NRXS N/A
- EPS Growth
- FGNX N/A
- NRXS N/A
- EPS
- FGNX 2.41
- NRXS N/A
- Revenue
- FGNX $24,184,000.00
- NRXS $3,217,531.00
- Revenue This Year
- FGNX N/A
- NRXS $62.14
- Revenue Next Year
- FGNX N/A
- NRXS $131.87
- P/E Ratio
- FGNX $1.59
- NRXS N/A
- Revenue Growth
- FGNX 24.03
- NRXS 41.93
- 52 Week Low
- FGNX $3.35
- NRXS $1.33
- 52 Week High
- FGNX $41.25
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- FGNX N/A
- NRXS 60.92
- Support Level
- FGNX N/A
- NRXS $2.85
- Resistance Level
- FGNX N/A
- NRXS $3.94
- Average True Range (ATR)
- FGNX 0.00
- NRXS 0.30
- MACD
- FGNX 0.00
- NRXS 0.05
- Stochastic Oscillator
- FGNX 0.00
- NRXS 65.77
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).